Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas

ClinicalTrials.gov ID: NCT05392374

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT05392374. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is an intermediate-size expanded access protocol to provide ONC201 to patients with diffuse intrinsic pontine gliomas who cannot access ONC201 through clinical trials.

Study identification

NCT ID: NCT05392374
Recruitment status: No Longer Available
Study type: Expanded access
Phase: Not listed
Lead sponsor: Jazz Pharmaceuticals; Industry
Enrollment: Not listed

Conditions and interventions

Conditions

Glioma

Interventions

ONC201 Drug

Drug

Eligibility (public fields only)

Age range: 6 Months to 18 Years
Sex: Not listed
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Not listed
Primary completion: Not listed
Completion: Not listed
Last update posted: May 26, 2022

United States locations

U.S. sites: 10
U.S. states: 7
U.S. cities: 9

Facility	City	State	ZIP	Site status
University of California San Francisco	San Francisco	California	94143	—
Children's Hospital Colorado	Aurora	Colorado	80045	—
Children's National Medical Center	Washington D.C.	District of Columbia	20010	—
Children's Healthcare of Atlanta	Atlanta	Georgia	30342	—
University of Michigan	Ann Arbor	Michigan	48109	—
University of Nebraska Medical Center	Omaha	Nebraska	68198	—
Albany Medical Center	Albany	New York	12208	—
NYU Langone Health	New York	New York	10016	—
Stephen Hassenfeld Children's Center for Cancer and Blood Disorders (NYU)	New York	New York	10016	—
University of Rochester Medical Center	Rochester	New York	14642	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05392374, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 26, 2022 · Synced Nov 15, 2026